Orexin receptor subtype activation and locomotor behaviour in the rat

Acta Physiologica

Volumn 198, Issue 3, 2010, Pages 313-324

  Samson, W K ^a   Bagley, S L ^a   Ferguson, A V ^b   White, M M ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

Locomotor behaviour; Orexin; Orexin receptors; Stereotypy

Indexed keywords

1 (6,8 DIFLUORO 2 METHYL 4 QUINOLINYL) 3 (4 DIMETHYLAMINOPHENYL)UREA; OREXIN 1 RECEPTOR; OREXIN 1 RECEPTOR ANTAGONIST; OREXIN 2 RECEPTOR; OREXIN 2 RECEPTOR ANTAGONIST; OREXIN A; OREXIN B; OREXIN B [ALANINE 11 LEUCINE 15]; RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; CONFERENCE PAPER; CONTROLLED STUDY; DRUG SELECTIVITY; HORMONE ACTION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAVENTRICULAR; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MOTOR ACTIVITY; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE;

EID: 75749105401     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2009.02056.x     Document Type: Conference Paper

References (37)

1. Al-Barzanji, K.A., Wilson, S., Baker, J., Jessop, D.S. Harbuz, M.S. 2001. Central orexin-A activates the hypothalamic-pituitary-adrenal axis and stimulates hypothalamic corticotropin releasing factor and arginine vasopressin neurons in conscious rats. J Neuroendocrinol 13, 421 424.
2. Asahi, S., Egashira, S., Matsuda, M., Iwaasa, H., Kanatani, A., Ohkuba, M., Ihara, M. Morishima, H. 2003. Development of an orexin-2 receptor selective agonist, [Ala(11),D-Leu(15)]orexin-B. Bioorg Med Chem Lett 13, 111 113.
3. Backberg, M., Hervieu, G., Wilson, S. Meister, B. 2002. Orexin receptor-1 (OX-R1) immunoreactivity in chemically identified neurons of the hypothalamus: focus on orexin targets involved in control of food and water intake. Eur J Neurosci 15, 315 328.
4. Chemelli, R.M., Willie, J.T., Sinton, C.M., Elmquist, J.K., Scammell, T., Lee, C., Richardson, J.A., Williams, S.C., Xiong, Y., Kisanuki, Y., Nakazato, M., Hammer, R.H., Saper, C.B. Yanagisawa, M. 1999. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98, 437 451.
5. Chen, C.T., Hwang, L.L., Chang, J.K. Dunn, N.J. 2000. Pressor effects of orexins injected intracisternally and to rostral ventrolateral medulla of anesthetized rats. Am J Physiol 278, R692 R697.
6. Cluderay, J.E., Harrison, D.C. Hervieu, G.J. 2002. Protein distribution of the orexin-2 receptor in the rat central nervous system. Regul Pept 104, 131 144.
7. DeLecea, L., Kilduff, T.S., Peyron, C., Xao, X.B., Foye, P.E., Danielson, P.E., Fukuhara, C., Battenberg, E.L.F., Gautvik, V.T., Bartlett, F.S., Frenkel, N., van den Pol, A.N., Bloom, F.E., Gautvik, K.M. Sutcliffe, J.G. 1998. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 96, 748 753.
8. Ferguson, A.V. Samson, W.K. 2003. The orexin/hypocretin system: a critical regulator of neuroendocrine and autonomic function. Front Neuroendocrinol 24, 141 150.
9. Fujiki, N., Yoshida, Y., Ripley, B., Honda, K., Mignot, E. Nishino, S. 2001. Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 hours and in response to food deprivation. Neuroreport 12, 993 997.
10. Hagan, J.J., Leslie, R.S., Patel, S., Evans, M.L., Wattam, T.A., Holmes, S., Benham, C.D., Taylor, S.G., Routledge, C., Hemmati, P. et al. 1999. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci USA 96, 10911 10916.
11. Hara, J., Beuckmann, C.T., Nambu, T., Willie, J.T., Chemelli, R.M., Sinton, C.M., Sugiyama, F., Yagami, K., Goto, K., Yanagisawa, M. Sakurai, T. 2001. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 30, 345 354.
12. Hervieu, G.J., Cluderay, J.E., Harrison, D.C., Roberts, J.C. Leslie, R.A. 2001. Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord. Neuroscience 103, 777 797.
13. Ida, T., Nakahara, K., Murakami, T., Hanada, R., Nakazato, M. Murakami, N. 2000. Possible involvement of orexin in the stress reaction in rats. Biochem Biophys Res Commun 270, 318 323.
14. Jaszberenyi, M., Bujdoso, E., Pataki, I. Telegdy, G. 2000. Effects of orexins on the hypothalamic-pituitary-adrenal system. J Neuroendocrinol 12, 1174 1178.
15. Kiwaki, K., Kotz, C.M., Wang, C., Lanningham-Foster, L. Levine, J. 2004. Orexin A (hypocretin 1) injected into hypothalamic paraventricular nucleus and spontaneous activity in rats. Am J Physiol 286, 551 559.
16. Langmead, C.J., Jerman, J.C., Brough, S.J., Scott, C., Porter, R.A. Herdon, H.J. 2004. Characterisation of the binding of [3H]-SB-674042, a novel nonpeptide antagonist, to the human orexin-1 receptor. Br J Pharmacol 141, 340 346.
17. Lu, X.Y., Bagnol, D., Burke, S., Akil, H. Watson, S.J. 2000. Differential distribution and regulation of OX1 and OX2 orexin/hypocretin receptor messenger RNA in the brain upon fasting. Horm Behav 37, 335 344.
18. Machado, B.H., Bonagamba, L.G., Dunn, S.L., Kwok, E.H. Dunn, N.J. 2002. Pressor response to microinjection of orexin/hypocretin into rostral ventrolateral medulla of awake rats. Regul Pept 104, 75 81.
19. Marcus, J.N., Aschkenasi, C.J., Lee, C.E., Chemelli, R.M., Saper, C.B., Yanagisawa, M. Elmquist, J.K. 2001. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 435, 6 25.
20. Mieda, M., Willie, J.T., Hara, J., Sinton, C.M., Sakurai, T. Yanagisawa, M. 2004. Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice. Proc Natl Acad Sci USA 101, 4649 4654.
21. Mileykovskiy, B.Y., Kiyashchenko, L.I. Siegel, J.M. 2005. Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron 46, 787 798.
22. Russell, S.H., Small, C.J., Dakin, C.L., Abbott, C.R., Morgan, D.G.A., Ghatei, M.A. Bloom, S.R. 2001. The central effects of orexin-A in the hypothalamic-pituitary-adrenal axis in vivo and in vitro in male rats. J Neuroendocrinol 13, 561 566.
23. Sakamoto, F., Yamada, S. Ueta, Y. 2004. Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons. Regul Pept 118, 183 191.
24. Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R.M., Tanaka, H., Williams, S.C., Richardson, J.A., Kozlowski, G.P., Wilson, S. et al. 1998. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92, 573 585.
25. Samson, W.K., Gosnell, B., Chang, J.K., Resch, Z.T. Murphy, T.C. 1999. Cardiovascular regulatory actions of the hypocretins in brain. Brain Res 831, 248 253.
26. Samson, W.K., Taylor, M.M., Follwell, M.J. Ferguson, A.V. 2002. Orexin actions in hypothalamic paraventricular nucleus: physiological consequences and cellular correlates. Regul Pept 104, 97 103.
27. Samson, W.K., Bagley, S.L., Ferguson, A.V. White, M.M. 2007. The hypocretin/orexin type 1 receptor in brain: a role in cardiovascular control and the neuroendocrine response to immobilization stress. Am J Physiol 292, R382 R387.
28. Shirasaka, T., Miyahara, S., Kunitake, T., Jin, Q.H., Kato, K., Takasaki, M. Kannan, H. 2001. Orexin depolarizes rat hypothalamic paraventricular nucleus neurons. Am J Physiol 281, R1114 R1118.
29. Shirasaka, T., Nakazato, M., Matsukura, S., Takasaki, M. Kannan, H. 1999. Sympathetic and cardiovascular actions of the orexins in conscious rats. Am J Physiol 277, R1780 R1785.
30. Smith, P.M., Connolly, B.C. Ferguson, A.V. 2002. Microinjection of orexin into the rat nucleus tractus solitarius causes increases in blood pressure. Brain Res 950, 261 267.
31. Steimer, T. Driscoll, P. 2003. Divergent stress responses and coping styles in psychogenetically selected Roman High-(RHA) and Lo-(RLA) avoidance rats: behavioral, neruoendocrine and developmental aspects. Stress 6, 87 100.
32. Suzuki, M., Beuckman, C.T., Shikata, K., Ogura, H. Sawai, T. 2005. Orexin A (hypocretin-1) is possibly involved in generation of anxiety-like behavior. Brain Res 1044, 116 121.
33. Taheri, S., Zeitzer, J.M. Mignot, E. 2002. The role of hypocretins (orexins) in sleep regulation and narcolepsy. Annu Rev Neurosci 25, 283 313.
34. Thannickal, T.C., Moore, R.Y., Nienhuis, R., Ramanathan, L., Gukyani, S., Aldrich, M., Cornford, M. Siegel, J.M. 2000. Reduced number of hypocretin neurons in human narcolepsy. Neuron 27, 469 474.
35. Willie, J.T., Chemelli, R.M., Sinton, C.M. Yanagisawa, M. 2001. To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu Rev Neurosci 24, 429 458.
36. Wilson, R.C., Vacek, T., Lanier, D.L. Dewsbury, D.A. 1976. Open-field behavior in muroid rodents. Behav Biol 17, 495 506.
37. Zhang, S., Lin, L., Thankchan, S., Blanco-Centurion, C., Yanagisawa, M., Mignot, E. Shiromani, P.J. 2007. The development of hypocretin (orexin) deficiency in hypocretin/ataxin-3 transgenic rats. Neuroscience 148, 34 43.